Elanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.18, $0.13 better than the analyst estimate of $0.05. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Elanco Animal Health sees FY2023 EPS of $0.80-$0.89, versus the consensus of $0.80. Elanco Animal Health sees FY2023 revenue of $4.35-4.41 billion, versus the consensus of $4.35 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.